Clinical Roundup UF researchers develop new CRISPR-based tool for cancer diagnosis April 28, 2023Vol.49 No.17
Clinical Roundup Cannabis may ease ‘chemo brain,’ improve sleep for cancer patients, study shows April 28, 2023Vol.49 No.17
Clinical Roundup IU cancer center researcher leads first-in-human multiple myeloma study with 90.5% response rate April 21, 2023Vol.49 No.16
Clinical Roundup IU cancer researchers identify target for breast cancer therapy April 21, 2023Vol.49 No.16
Clinical Roundup Moderna, Merck present positive phase IIb data on neoantigen cancer vaccine + Keytruda for melanoma April 21, 2023Vol.49 No.16
Clinical Roundup Immunotherapy treatment alone produces “exceptional” response rates in some melanoma patients April 21, 2023Vol.49 No.16
Clinical Roundup Vitamin D may play a role in prostate cancer disparities, Cedars-Sinai researchers find April 21, 2023Vol.49 No.16
Clinical Roundup Basket trial results suggest advanced FGFR-altered solid tumors may benefit from FGFR inhibitor pemigatinib April 21, 2023Vol.49 No.16
Clinical Roundup Combination PARP and ATR inhibitors show positive early results April 21, 2023Vol.49 No.16
Clinical Roundup Phase I MD Anderson study shows YAP/TEAD inhibitor VT3989 is well tolerated and shows antitumor activity in advanced mesothelioma and NF2-mutant cancers April 21, 2023Vol.49 No.16
